BackgroundCholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNAs have been involved in the pathogenesis of different cancer types, including cholangiocarcinoma. Our aim was to identify novel microRNAs regulating cholangiocarcinoma cell growth in vitro and in vivo.MethodsA functional microRNA library screen was performed in human cholangiocarcinoma cells to identify microRNAs that regulate cholangiocarcinoma cell growth. Real-time PCR analysis evaluated miR-9 and XIAP mRNA levels in cholangiocarcinoma cells and tumors.ResultsThe screen identified 21 microRNAs that regulated >50 % cholangiocarcinoma cell growth. MiR-410 was identified as the top suppressor of growth, while its overexpression signific...
BACKGROUND AND AIMS: Cholangiocarcinoma (CCA) is highly resistant to chemotherapy, including gemcita...
miR-17-92 is an oncogenic miRNA cluster implicated in the development of several cancers; however, i...
Background & Aims: Cholangiocarcinoma (CCA) is a heterogeneous and lethal malignancy, the molecular ...
BackgroundCholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNAs ...
Background: Cholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNA...
Accumulating evidence has demonstrated that microRNAs (miRNAs or miRs) play an important role in the...
Recent evidence has suggested an important role of miRNAs in liver biology and diseases, although th...
Lili Gao,1,* Xiaoping Yang,2,* Hao Zhang,2 Minghua Yu,3 Jianting Long,4 Tao Yang1 1Center for Medic...
BACKGROUND: Although many studies have confirmed a relationship between microRNAs (miRNAs) and chola...
Background: Although many studies have confirmed a relationship between microRNAs (miRNAs) and chola...
Cholangiocarcinoma (CCA), an aggressive malignancy, is typically diagnosed at an advanced stage. It ...
Background & Aims: Cholangiocarcinomas (CCA) are resistant to chemotherapy, so new therapeutic agent...
It has been established that microRNA expression and function contribute to phenotypic features of m...
Increased apoptotic activity in xenograft tumors (day 35) treated with miR-410 relative to miR-NC, a...
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, chol...
BACKGROUND AND AIMS: Cholangiocarcinoma (CCA) is highly resistant to chemotherapy, including gemcita...
miR-17-92 is an oncogenic miRNA cluster implicated in the development of several cancers; however, i...
Background & Aims: Cholangiocarcinoma (CCA) is a heterogeneous and lethal malignancy, the molecular ...
BackgroundCholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNAs ...
Background: Cholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNA...
Accumulating evidence has demonstrated that microRNAs (miRNAs or miRs) play an important role in the...
Recent evidence has suggested an important role of miRNAs in liver biology and diseases, although th...
Lili Gao,1,* Xiaoping Yang,2,* Hao Zhang,2 Minghua Yu,3 Jianting Long,4 Tao Yang1 1Center for Medic...
BACKGROUND: Although many studies have confirmed a relationship between microRNAs (miRNAs) and chola...
Background: Although many studies have confirmed a relationship between microRNAs (miRNAs) and chola...
Cholangiocarcinoma (CCA), an aggressive malignancy, is typically diagnosed at an advanced stage. It ...
Background & Aims: Cholangiocarcinomas (CCA) are resistant to chemotherapy, so new therapeutic agent...
It has been established that microRNA expression and function contribute to phenotypic features of m...
Increased apoptotic activity in xenograft tumors (day 35) treated with miR-410 relative to miR-NC, a...
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, chol...
BACKGROUND AND AIMS: Cholangiocarcinoma (CCA) is highly resistant to chemotherapy, including gemcita...
miR-17-92 is an oncogenic miRNA cluster implicated in the development of several cancers; however, i...
Background & Aims: Cholangiocarcinoma (CCA) is a heterogeneous and lethal malignancy, the molecular ...